Morgan Stanley’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Buy |
|
|||||
|
2025
Q1 | $1.59M | Sell |
|
|||||
|
2024
Q4 | $2.15M | Buy |
|
|||||
|
2024
Q3 | $885K | Buy |
|
|||||
|
2024
Q2 | $307K | Sell |
|
|||||
|
2024
Q1 | $523K | Sell |
|
|||||
|
2023
Q4 | $971K | Buy |
|
|||||
|
2023
Q3 | $135K | Sell |
|
|||||
|
2023
Q2 | $262K | Buy |
|
|||||
|
2023
Q1 | $265K | Buy |
|
|||||
|
2022
Q4 | $48.1K | Sell |
|
|||||
|
2022
Q3 | $109K | Sell |
|
|||||
|
2022
Q2 | $248K | Buy |
|
|||||
|
2022
Q1 | $72K | Sell |
|
|||||
|
2021
Q4 | $143K | Sell |
|
|||||
|
2021
Q3 | $407K | Buy |
|
|||||
|
2021
Q2 | $272K | Buy |
|
|||||
|
2021
Q1 | $93K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1K | Sell |
|
|||||
|
2019
Q4 | $3K | Sell |
|
|||||
|
2019
Q3 | $13K | Sell |
|
|||||
|
2019
Q2 | $48K | Sell |
|
|||||
|
2019
Q1 | $51K | Sell |
|
|||||
|
2018
Q4 | $106K | Sell |
|
|||||
|
2018
Q3 | $398K | Sell |
|
|||||
|
2018
Q2 | $972K | Buy |
|
|||||
|
2018
Q1 | $276K | Buy |
|
|||||
|
2017
Q4 | $104K | Sell |
|
|||||
|
2017
Q3 | $111K | Sell |
|
|||||
|
2017
Q2 | $121K | Sell |
|
|||||
|
2017
Q1 | $151K | Buy |
|
|||||
|
2016
Q4 | $15K | Buy |
|
|||||
|
2016
Q3 | $17K | Sell |
|
|||||
|
2016
Q2 | $16K | Sell |
|
|||||
|
2016
Q1 | $183K | Buy |
|
|||||
|
2015
Q4 | $62K | Sell |
|
|||||
|
2015
Q3 | $74K | Buy |
|
|||||
|
2015
Q2 | $54K | Buy |
|